RAPAMYCIN IN THE TREATMENT OF GLOMERULOPATHY

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study seeks to determine whether a 3-month course of rapamycin reduces proteinuria and improves glomerular function in adult patients with nephrotic syndrome due to minimal change nephropathy, focal segmental glomerulosclerosis and membranous nephropathy.